RiverGlades Family Offices’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-1,900
Closed -$278K 85
2024
Q2
$278K Hold
1,900
0.22% 64
2024
Q1
$285K Buy
+1,900
New +$302K 0.23% 62
2020
Q3
Sell
-3,450
Closed -$485K 69
2020
Q2
$485K Sell
3,450
-300
-8% -$43.7K 0.5% 35
2020
Q1
$492K Hold
3,750
0.52% 36
2019
Q4
$547K Hold
3,750
0.47% 38
2019
Q3
$485K Buy
3,750
+700
+23% +$92.2K 0.43% 39
2019
Q2
$425K Hold
3,050
0.38% 43
2019
Q1
$426K Buy
+3,050
New +$409K 0.39% 44
2018
Q4
Sell
-3,050
Closed -$421K 62
2018
Q3
$421K Hold
3,050
0.36% 42
2018
Q2
$370K Buy
3,050
+1,193
+64% +$149K 0.32% 48
2018
Q1
$238K Buy
+1,857
New +$251K 0.19% 70

Other funds holding JNJ

RiverGlades Family Offices's JNJ Position: Q3 2024 in Review

RiverGlades Family Offices sold out of Johnson & Johnson (JNJ) in Q3 2024, closing a stake of 1,900 shares — an estimated $278K sold.

RiverGlades Family Offices first reported a position in JNJ in Q1 2018 and held it in 11 quarters. The position peaked at $547K in Q4 2019. 3,881 funds tracked by Wall St. Rank hold JNJ as of Q3 2024.

  • RiverGlades Family Offices reported no remaining Johnson & Johnson position as of Q3 2024 after selling out during the quarter.
  • RiverGlades Family Offices sold 1,900 Johnson & Johnson shares in Q3 2024, an estimated $278K.
  • RiverGlades Family Offices first reported a position in Johnson & Johnson in Q1 2018 and held it in 11 quarters.
  • RiverGlades Family Offices's Johnson & Johnson position peaked at $547K in Q4 2019.
  • 3,881 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2024.

Based on RiverGlades Family Offices's 13F filing for Q3 2024, filed 13 Nov 2024.